Previous studies found that SAA can promote atherosclerosis development by recruiting monocytes and polymorphonuclear leukocytes [10], increasing HDL binding to macrophages and endothelial cells [11], inducing endothelial dysfunction [12], and lessening VSMC lipid biosynthesis [13]. This evidence concerns the gene SAA1 and endothelial dysfunction.